Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1996 Jun;58(6):1192–1204.

X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.

A Renieri 1, M Bruttini 1, L Galli 1, P Zanelli 1, T Neri 1, S Rossetti 1, A Turco 1, N Heiskari 1, J Zhou 1, R Gusmano 1, L Massella 1, G Banfi 1, F Scolari 1, A Sessa 1, G Rizzoni 1, K Tryggvason 1, P F Pignatti 1, M Savi 1, A Ballabio 1, M De Marchi 1
PMCID: PMC1915065  PMID: 8651296

Abstract

The COL4A5 gene encodes the alpha5 (type IV) collagen chain and is defective in X-linked Alport syndrome (AS). Here, we report the first systematic analysis of all 51 exons of COL4A5 gene in a series of 201 Italian AS patients. We have previously reported nine major rearrangements, as well as 18 small mutations identified in the same patient series by SSCP analysis of several exons. After systematic analysis of all 51 exons of COL4A5, we have now identified 30 different mutations: 10 glycine substitutions in the triple helical domain of the protein, 9 frameshift mutations, 4 in-frame deletions, 1 start codon, 1 nonsense, and 5 splice-site mutations. These mutations were either unique or found in two unrelated families, thus excluding the presence of a common mutation in the coding part of the gene. Overall, mutations were detected in only 45% of individuals with a certain or likely diagnosis of X-linked AS. This finding suggests that mutations in noncoding segments of COL4A5 account for a high number of X-linked AS cases. An alternative hypothesis is the presence of locus heterogeneity, even within the X-linked form of the disease. A genotype/phenotype comparison enabled us to better substantiate a significant correlation between the degree of predicted disruption of the alpha5 chain and the severity of phenotype in affected male individuals. Our study has significant implications in the diagnosis and follow-up of AS patients.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker D. F., Hostikka S. L., Zhou J., Chow L. T., Oliphant A. R., Gerken S. C., Gregory M. C., Skolnick M. H., Atkin C. L., Tryggvason K. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990 Jun 8;248(4960):1224–1227. doi: 10.1126/science.2349482. [DOI] [PubMed] [Google Scholar]
  2. Beaudet A. L., Tsui L. C. A suggested nomenclature for designating mutations. Hum Mutat. 1993;2(4):245–248. doi: 10.1002/humu.1380020402. [DOI] [PubMed] [Google Scholar]
  3. Boye E., Flinter F., Zhou J., Tryggvason K., Bobrow M., Harris A. Detection of 12 novel mutations in the collagenous domain of the COL4A5 gene in Alport syndrome patients. Hum Mutat. 1995;5(3):197–204. doi: 10.1002/humu.1380050303. [DOI] [PubMed] [Google Scholar]
  4. Byers P. H. Brittle bones--fragile molecules: disorders of collagen gene structure and expression. Trends Genet. 1990 Sep;6(9):293–300. doi: 10.1016/0168-9525(90)90235-x. [DOI] [PubMed] [Google Scholar]
  5. Dockhorn-Dworniczak B., Dworniczak B., Brömmelkamp L., Bülles J., Horst J., Böcker W. W. Non-isotopic detection of single strand conformation polymorphism (PCR-SSCP): a rapid and sensitive technique in diagnosis of phenylketonuria. Nucleic Acids Res. 1991 May 11;19(9):2500–2500. doi: 10.1093/nar/19.9.2500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Feingold J., Bois E., Chompret A., Broyer M., Gubler M. C., Grünfeld J. P. Genetic heterogeneity of Alport syndrome. Kidney Int. 1985 Apr;27(4):672–677. doi: 10.1038/ki.1985.63. [DOI] [PubMed] [Google Scholar]
  7. Flinter F. A., Cameron J. S., Chantler C., Houston I., Bobrow M. Genetics of classic Alport's syndrome. Lancet. 1988 Oct 29;2(8618):1005–1007. doi: 10.1016/s0140-6736(88)90753-2. [DOI] [PubMed] [Google Scholar]
  8. Forrest S., Cotton R., Landegren U., Southern E. How to find all those mutations. Nat Genet. 1995 Aug;10(4):375–376. doi: 10.1038/ng0895-375. [DOI] [PubMed] [Google Scholar]
  9. Govan J. A. Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes? Br J Ophthalmol. 1983 Aug;67(8):493–503. doi: 10.1136/bjo.67.8.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Grompe M. The rapid detection of unknown mutations in nucleic acids. Nat Genet. 1993 Oct;5(2):111–117. doi: 10.1038/ng1093-111. [DOI] [PubMed] [Google Scholar]
  11. Gubler M. C., Antignac C., Deschênes G., Knebelmann B., Hors-Cayla M. C., Grünfeld J. P., Broyer M., Habib R. Genetic, clinical, and morphologic heterogeneity in Alport's syndrome. Adv Nephrol Necker Hosp. 1993;22:15–35. [PubMed] [Google Scholar]
  12. Guo C., Van Damme B., Van Damme-Lombaerts R., Van den Berghe H., Cassiman J. J., Marynen P. Differential splicing of COL4A5 mRNA in kidney and white blood cells: a complex mutation in the COL4A5 gene of an Alport patient deletes the NC1 domain. Kidney Int. 1993 Dec;44(6):1316–1321. doi: 10.1038/ki.1993.384. [DOI] [PubMed] [Google Scholar]
  13. Hasstedt S. J., Atkin C. L., San Juan A. C., Jr Genetic heterogeneity among kindreds with Alport syndrome. Am J Hum Genet. 1986 Jun;38(6):940–953. [PMC free article] [PubMed] [Google Scholar]
  14. Heidet L., Dahan K., Zhou J., Xu Z., Cochat P., Gould J. D., Leppig K. A., Proesmans W., Guyot C., Guillot M. Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours. Hum Mol Genet. 1995 Jan;4(1):99–108. doi: 10.1093/hmg/4.1.99. [DOI] [PubMed] [Google Scholar]
  15. Knebelmann B., Deschenes G., Gros F., Hors M. C., Grünfeld J. P., Zhou J., Tryggvason K., Gubler M. C., Antignac C. Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. Am J Hum Genet. 1992 Jul;51(1):135–142. [PMC free article] [PubMed] [Google Scholar]
  16. Krawczak M., Cooper D. N. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet. 1991 Mar;86(5):425–441. doi: 10.1007/BF00194629. [DOI] [PubMed] [Google Scholar]
  17. Lakich D., Kazazian H. H., Jr, Antonarakis S. E., Gitschier J. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet. 1993 Nov;5(3):236–241. doi: 10.1038/ng1193-236. [DOI] [PubMed] [Google Scholar]
  18. Lemmink H. H., Mochizuki T., van den Heuvel L. P., Schröder C. H., Barrientos A., Monnens L. A., van Oost B. A., Brunner H. G., Reeders S. T., Smeets H. J. Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet. 1994 Aug;3(8):1269–1273. doi: 10.1093/hmg/3.8.1269. [DOI] [PubMed] [Google Scholar]
  19. Lemmink H. H., Schröder C. H., Brunner H. G., Nelen M. R., Zhou J., Tryggvason K., Haagsma-Schouten W. A., Roodvoets A. P., Rascher W., van Oost B. A. Identification of four novel mutations in the COL4A5 gene of patients with Alport syndrome. Genomics. 1993 Aug;17(2):485–489. doi: 10.1006/geno.1993.1351. [DOI] [PubMed] [Google Scholar]
  20. MOL W. [Growth disorders after injury of the epiphyses in children]. Ned Tijdschr Geneeskd. 1962 Feb 3;106:201–204. [PubMed] [Google Scholar]
  21. Massella L., Rizzoni G., De Blasis R., Barsotti P., Faraggiana T., Renieri A., Seri M., Galli L., De Marchi M. De-novo COL4A5 gene mutations in Alport's syndrome. Nephrol Dial Transplant. 1994;9(10):1408–1411. [PubMed] [Google Scholar]
  22. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  23. Peissel B., Geng L., Kalluri R., Kashtan C., Rennke H. G., Gallo G. R., Yoshioka K., Sun M. J., Hudson B. G., Neilson E. G. Comparative distribution of the alpha 1(IV), alpha 5(IV), and alpha 6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J Clin Invest. 1995 Oct;96(4):1948–1957. doi: 10.1172/JCI118241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Peissel B., Rossetti S., Renieri A., Galli L., De Marchi M., Battini G., Meroni M., Sessa A., Schiavano S., Pignatti P. F. A novel frameshift deletion in type IV collagen alpha 5 gene in a juvenile-type Alport syndrome patient: an adenine deletion (2940/2943 del A) in exon 34 of COL4A5. Hum Mutat. 1994;3(4):386–390. doi: 10.1002/humu.1380030410. [DOI] [PubMed] [Google Scholar]
  25. Renieri A., Bassi M. T., Galli L., Zhou J., Giani M., De Marchi M., Ballabio A. Deletion spanning the 5' ends of both the COL4A5 and COL4A6 genes in a patient with Alport's syndrome and leiomyomatosis. Hum Mutat. 1994;4(3):195–198. doi: 10.1002/humu.1380040304. [DOI] [PubMed] [Google Scholar]
  26. Renieri A., Galli L., De Marchi M., Li Volti S., Mollica F., Lupo A., Maschio G., Peissel B., Rossetti S., Pignatti P. Single base pair deletions in exons 39 and 42 of the COL4A5 gene in Alport syndrome. Hum Mol Genet. 1994 Jan;3(1):201–202. doi: 10.1093/hmg/3.1.201. [DOI] [PubMed] [Google Scholar]
  27. Renieri A., Galli L., Grillo A., Bruttini M., Neri T., Zanelli P., Rizzoni G., Massella L., Sessa A., Meroni M. Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. Am J Med Genet. 1995 Nov 20;59(3):380–385. doi: 10.1002/ajmg.1320590320. [DOI] [PubMed] [Google Scholar]
  28. Renieri A., Meroni M., Sessa A., Battini G., Serbelloni P., Torri Tarelli L., Seri M., Galli L., De Marchi M. Variability of clinical phenotype in a large Alport family with Gly 1143 Ser change of collagen alpha 5(IV)-chain. Nephron. 1994;67(4):444–449. doi: 10.1159/000188020. [DOI] [PubMed] [Google Scholar]
  29. Renieri A., Seri M., Galli L., Cosci P., Imbasciati E., Massella L., Rizzoni G., Restagno G., Carbonara A. O., Stramignoni E. Small frameshift deletions within the COL4A5 gene in juvenile-onset Alport syndrome. Hum Genet. 1993 Oct;92(4):417–420. doi: 10.1007/BF01247348. [DOI] [PubMed] [Google Scholar]
  30. Renieri A., Seri M., Myers J. C., Pihlajaniemi T., Massella L., Rizzoni G., De Marchi M. De novo mutation in the COL4A5 gene converting glycine 325 to glutamic acid in Alport syndrome. Hum Mol Genet. 1992 May;1(2):127–129. doi: 10.1093/hmg/1.2.127. [DOI] [PubMed] [Google Scholar]
  31. Richard I., Beckmann J. S. How neutral are synonymous codon mutations? Nat Genet. 1995 Jul;10(3):259–259. doi: 10.1038/ng0795-259. [DOI] [PubMed] [Google Scholar]
  32. Schiaffino M. V., Bassi M. T., Galli L., Renieri A., Bruttini M., De Nigris F., Bergen A. A., Charles S. J., Yates J. R., Meindl A. Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. Hum Mol Genet. 1995 Dec;4(12):2319–2325. doi: 10.1093/hmg/4.12.2319. [DOI] [PubMed] [Google Scholar]
  33. Tryggvason K., Zhou J., Hostikka S. L., Shows T. B. Molecular genetics of Alport syndrome. Kidney Int. 1993 Jan;43(1):38–44. doi: 10.1038/ki.1993.8. [DOI] [PubMed] [Google Scholar]
  34. Turco A. E., Rossetti S., Biasi M. O., Rizzoni G., Massella L., Saarinen N. H., Renieri A., Pignatti P. F., De Marchi M. A novel missense mutation in exon 3 of the COL4A5 gene associated with late-onset Alport syndrome. Clin Genet. 1995 Nov;48(5):261–263. doi: 10.1111/j.1399-0004.1995.tb04101.x. [DOI] [PubMed] [Google Scholar]
  35. Wang Q., Orrison B. M., Marini J. C. Two additional cases of osteogenesis imperfecta with substitutions for glycine in the alpha 2(I) collagen chain. A regional model relating mutation location with phenotype. J Biol Chem. 1993 Nov 25;268(33):25162–25167. [PubMed] [Google Scholar]
  36. Yap E. P., McGee J. O. Nonisotopic SSCP detection in PCR products by ethidium bromide staining. Trends Genet. 1992 Feb;8(2):49–49. doi: 10.1016/0168-9525(92)90339-6. [DOI] [PubMed] [Google Scholar]
  37. Zhou J., Leinonen A., Tryggvason K. Structure of the human type IV collagen COL4A5 gene. J Biol Chem. 1994 Mar 4;269(9):6608–6614. [PubMed] [Google Scholar]
  38. Zhou J., Mochizuki T., Smeets H., Antignac C., Laurila P., de Paepe A., Tryggvason K., Reeders S. T. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science. 1993 Aug 27;261(5125):1167–1169. doi: 10.1126/science.8356449. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES